Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting

Philipp Albrecht; IK Bjorna; David Brassat; Rachel Farrell; Peter Feys; Jeremy Hobart; Raymond Hupperts; Michael Linnebank; J Magdic; Celia Oreja-Guevara; Carlo Pozzilli; Antonio Vasco Salgado; Tjalf Ziemssen

doi:10.1177/1756286418803248

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting

Philipp Albrecht^*
, IK Bjorna
, David Brassat
, Rachel Farrell
, Peter Feys
, Jeremy Hobart
, Raymond Hupperts
, Michael Linnebank
, J Magdic
, Celia Oreja-Guevara
, Carlo Pozzilli
, Antonio Vasco Salgado
, Tjalf Ziemssen

^*Corresponding author for this work

Peninsula Medical School

Heinrich Heine University Düsseldorf
Université de Toulouse III
University College London
Hasselt University
Department of Clinical Trials and Health Research: Translational & Stratified Medicine
Zuyderland
Helios Clinic Hagen-Ambrock
Complutense University
University of Rome La Sapienza
Hospital Fernando Fonseca
Technische Universität Dresden

Research output: Contribution to journal › Article › peer-review

24 Downloads (Pure)

Original language	English
Number of pages	0
Journal	Therapeutic Advances in Neurological Disorders
Volume	0
Issue number	0
Early online date	5 Oct 2018
DOIs	https://doi.org/10.1177/1756286418803248
Publication status	Published - 5 Oct 2018

Access to Document

10.1177/1756286418803248

Revision1 Albrecht FAM Expert consensus Ther Adv Neurol Disord Manuscript Draft 1v2 FAM-17668 totalfinal clean

Cite this

Albrecht, P., Bjorna, IK., Brassat, D., Farrell, R., Feys, P., Hobart, J., Hupperts, R., Linnebank, M., Magdic, J., Oreja-Guevara, C., Pozzilli, C., Salgado, A. V., & Ziemssen, T. (2018). Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting. Therapeutic Advances in Neurological Disorders, 0(0). https://doi.org/10.1177/1756286418803248

@article{a29a139ab4f04477853804f170af7136,

title = "Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting",

author = "Philipp Albrecht and IK Bjorna and David Brassat and Rachel Farrell and Peter Feys and Jeremy Hobart and Raymond Hupperts and Michael Linnebank and J Magdic and Celia Oreja-Guevara and Carlo Pozzilli and Salgado, \{Antonio Vasco\} and Tjalf Ziemssen",

year = "2018",

month = oct,

day = "5",

doi = "10.1177/1756286418803248",

language = "English",

volume = "0",

journal = "Therapeutic Advances in Neurological Disorders",

issn = "1756-2856",

publisher = "SAGE Publications Ltd",

number = "0",

}

Albrecht, P, Bjorna, IK, Brassat, D, Farrell, R, Feys, P, Hobart, J, Hupperts, R, Linnebank, M, Magdic, J, Oreja-Guevara, C, Pozzilli, C, Salgado, AV & Ziemssen, T 2018, 'Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting', Therapeutic Advances in Neurological Disorders, vol. 0, no. 0. https://doi.org/10.1177/1756286418803248

TY - JOUR

T1 - Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting

AU - Albrecht, Philipp

AU - Bjorna, IK

AU - Brassat, David

AU - Farrell, Rachel

AU - Feys, Peter

AU - Hobart, Jeremy

AU - Hupperts, Raymond

AU - Linnebank, Michael

AU - Magdic, J

AU - Oreja-Guevara, Celia

AU - Pozzilli, Carlo

AU - Salgado, Antonio Vasco

AU - Ziemssen, Tjalf

PY - 2018/10/5

Y1 - 2018/10/5

UR - https://pearl.plymouth.ac.uk/pms-research/464/

U2 - 10.1177/1756286418803248

DO - 10.1177/1756286418803248

M3 - Article

SN - 1756-2856

VL - 0

JO - Therapeutic Advances in Neurological Disorders

JF - Therapeutic Advances in Neurological Disorders

IS - 0

ER -

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting

Access to Document

Other files and links

Cite this